TuHURA Biosciences

We are a Phase 3 immuno-oncology company developing three distinct novel technologies and therapeutics to overcome primary and acquired resistance to existing cancer immunotherapies

Pipeline

Pipeline - February 2026

Sign Up
For Alerts!